Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Cash and Cash Equivalents [Axis]
Letter of Credit [Member]
JP Morgan Chase [Member]
Cash In US Bank [Member]
Cash Equivalents In US Treasury Bills [Member]
Cash In Australian Bank [Member]
Transaction Type [Axis]
Stock Based Compensation [Member]
Class of Stock [Axis]
Securities Financing Transaction [Axis]
May 2024 Public Offering [Member]
Class A Warrants [Member]
Class B Warrants [Member]
Prefunded Warrants [Member]
Counterparty Name [Axis]
Placement Agent [Member]
Placement Agent Warrants [Member]
Director 1 [Member]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
Director 2 [Member]
Director 3 [Member]
Director 4 [Member]
ATM 2022 Agreement [Member]
HC Wainwright [Member]
March 2025 Warrant Inducment [Member]
Options Held [Member]
RSU [Member]
Warrant [Member]
Exercise Price Range [Axis]
$4.64 or Below [Member]
$150.00 or Below [Member]
$200.00 - $220.00 [Member]
Equity Option [Member]
$102.40-112.8 [Member]
$201.6 [Member]
Non Employee Directors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Separation Agreement [Member]
Related Party Transaction [Axis]
Accrued Board Fees [Member]
Accrued Vacation To All Employees [Member]
Accrued Separation Expenses [Member]
Income Tax Jurisdiction [Axis]
Federal [Member]
State [Member]
Property Subject to or Available for Operating Lease [Axis]
Office And Laboratory Space [Member]
Manufacturing Space [Member]
Office Lab And Manufacturing Leases [Member]
Consolidation Items [Axis]
Operating Segments [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Name
Auditor Name
Auditor Name
Statement of Financial Position [Abstract]
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Deferred offering costs
Prepaid expenses and other current assets
TOTAL CURRENT ASSETS
Property and equipment, net
Operating lease right-of-use asset
Patents, net
Restricted cash
Deposits
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
Due to related parties
Operating lease liability, current portion
Other current liabilities
TOTAL CURRENT LIABILITIES
Operating lease liability, less current portion
TOTAL LIABILITIES
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 60,000,000 shares authorized at March 31, 2025 and 2024; 2,585,239 and 328,728 shares issued and 2,010,739 and 328,728 outstanding at March 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
OPERATING COSTS AND EXPENSES
Professional fees
Payroll and related expenses
General and administrative
Total operating expenses
OPERATING LOSS
OTHER EXPENSE (INCOME), NET
Interest income
Other income
Interest expense
Other expense
Total other expense (income), net
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
Basic loss per share attributable to common stockholders
Diluted loss per share attributable to common stockholders
Weighted average number of common shares outstanding - basic
Weighted average number of common shares outstanding - diluted
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
OTHER COMPREHENSIVE LOSS
COMPREHENSIVE LOSS
Statement [Table]
Statement [Line Items]
Beginning balance, value
Beginning balance, shares
Issuances of common stock for public offering
Issuances of common stock for public offering, shares
Issuances of common stock for Class A and Class B warrant exercises, net
Issuances of common stock for Class A and Class B warrant exercises, net, shares
Issuances of common stock for cash under at the market program, net
Issuances of common stock for cash under at the market program, net, shares
Rounding for reverse split
Rounding for reverse split, shares
Issuance of common shares upon vesting of restricted stock units and net stock option exercises
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares
Reversal of accrued commission liability
Stock-based compensation expense
Warrant inducement expense, net
Net loss
Other comprehensive loss
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Loss on disposal of property, plant and equipment
Non-cash lease expense
Warrant Inducement Expense
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable and other current liabilities
Due to related parties
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Cash used in investing activities
Cash flows from financing activities:
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units
Net proceeds from the issuance of common stock
Proceeds from exercise of warrants – standard terms
Proceeds from exercise of warrants – induced terms
Commission paid related to warrant inducement
Legal fees paid related to warrant inducement
Net cash provided by financing activities
Effect of Exchange Rate on Changes on Cash
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents restricted cash at beginning of year
Cash and restricted cash
Supplemental information of non-cash investing and financing activities:
Issuance of shares under vested restricted stock units, net stock option exercises and unvested share issuance for services
Disposal of fully depreciated property
Reversal of accrued commission liability (see Note 6)
Deferred offering costs not yet paid
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents
Restricted cash
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted [Flag]
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Award Timing Disclosures [Line Items]
Award Timing MNPI Considered [Flag]
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted [Flag]
Accounting Policies [Abstract]
ORGANIZATION, LIQUIDITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET
Goodwill and Intangible Assets Disclosure [Abstract]
PATENTS, NET
Equity [Abstract]
EQUITY TRANSACTIONS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Other Liabilities Disclosure [Abstract]
OTHER CURRENT LIABILITIES
Income Tax Disclosure [Abstract]
INCOME TAXES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Segment Reporting [Abstract]
SEGMENT REPORTING
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
ORGANIZATION
LIQUIDITY AND GOING CONCERN
PRINCIPLES OF CONSOLIDATION
RISKS AND UNCERTAINTIES
USE OF ESTIMATES
CASH AND CASH EQUIVALENTS
CONCENTRATIONS OF CREDIT RISKS
RESTRICTED CASH
PROPERTY AND EQUIPMENT
INCOME TAXES
LONG-LIVED ASSETS
LOSS PER SHARE
REVENUE RECOGNITION
STOCK-BASED COMPENSATION
PATENTS
STOCK PURCHASE WARRANTS
RESEARCH AND DEVELOPMENT EXPENSES
OFF-BALANCE SHEET ARRANGEMENTS
SIGNIFICANT RECENT ACCOUNTING PRONOUNCEMENTS
Schedule of cash and cash equivalents
Schedule of share-based compensation expenses
Schedule of property and equipment, net
Schedule of patents, net
Schedule of warrant activity
Schedule of warrant activity exercisable and outstanding
Schedule of options outstanding that have vested and are expected to vest
Schedule of stock option activity
Schedule of nonvested shares
Schedule of detail of options outstanding and exercisable by exercise price
Schedule of RSUs
Schedule of stock-based compensation
Schedule of amounts due to related parties
Schedule of other current liabilities
Schedule of deferred tax assets
Schedule of provision for income taxes
Schedule of lease maturity
Schedule of significant expense categories
Cash and Cash Equivalent [Table]
Cash and Cash Equivalents [Line Items]
Offsetting Assets [Table]
Offsetting Assets [Line Items]
Vesting of Stock Options and Restricted Stock Units
Total Stock-Based Compensation Expense
Basic loss per common share
Diluted loss per common share
Accumulated deficit
Cash balances over insured amount
Cash equivalents of US treasury bills
Converted to money market deposit account
Interest-bearing account
Uncertain tax positions
Asset impairment charges
Antidilutive shares
Research and development expenses
Furniture and office equipment, at cost
Less: disposals
Leasehold improvements
Gross property and equipment
Less: accumulated depreciation
Fixed assets, net
Depreciation expense
Initial cost of fully depreciated furniture and equipment disposal
Issued patents
Accumulated amortization
Patents, net
Amortization of patents
Weighted average remaining life of patents
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning balance
Weighted average exercise price, outstanding
Warrants granted
Weighted average exercise price, granted
Warrants exercised
Weighted average exercise price, exercised
Warrants cancelled/forfeited
Weighted average exercise price, cancelled/forfeited
Warrants outstanding, ending balance
Weighted average exercise price, outstanding
Warrants exercisable
Weighted average exercise price, exercisable
Warrants Outstanding
Weighted Average Remaining Life (Years)
Weighted Average Exercise Price, Outstanding
Warrants Exercisable
Weighted Average Exercise Price, Exercisable
Number of options, vested
Weighted average exercise price options vested
Weighted average remaining contractual term options vested
Number of options, expected to vest
Weighted average exercise price options expected to vest
Weighted average remaining contractual term options expected to vest
Total options outstanding
Stock options outstanding, beginning balance
Weighted average exercise price, beginning price
Stock options granted
Stock options cancelled/forfeited
Weighted average exercise price, cancelled/forfeited
Stock options outstanding, ending balance
Weighted average exercise price, ending price
Stock options exercisable
Weighted average exercise price, exercisable
Nonvested shares outstanding, beginning balance
Weighted average grant date fair value nonvested shares outstanding, beginning balance
Options vested
Weighted average grant date fair value nonvested shares outstanding, vested
Options forfeited
Weighted average grant date fair value nonvested shares outstanding, forfeited
Nonvested shares outstanding, ending balance
Stock options outstanding
Weighted average remaining life (years)
Weighted average exercise price, outstanding
RSUs nonvested
RSU's granted
RSU's vested
Tax withholding payments, shares
Stock based compensation
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Reverse stock split
New warrants exercised
Existing warrants exercised
Warrant or Right, Reason for Issuance, Description
Gross proceeds from exercise
Shares issued
Legal fees expenses
Sale of stock
Sale of stock per value
Warrants issued
Warrants per share exercise price
Warrants expiry date
Payment of other stock issuance costs
Gross proceeds from offering, before deducting placement fees and other offering expenses
Net proceeds, of offering deducting placement fees and expenses and other offering expenses payable
Proceeds from sale of equity
Number of shares granted
Terms of awards
Aggregate offering price
Securities remained available for sale
Proceeds from sale of common stock
Stock issued new, shares issued
Average per share sale price
Unvested stock outstanding
Issued warrants shares
issued of warrant inducement shares
Common stock for issuance through stock options, restricted stock units
Additional shares authorized for issuance during period
Shares available for grant
Stock option grants
Weighted average grant date fair value ofRSUs stock options granted
Stock option exercises
Intrinsic value per share
Unrecognized compensation cost related to share-based payments
Weighted average period
Related Party Transaction [Table]
Related Party Transaction [Line Items]
[custom:AccruedDirectorFees-0]
Accrued Vacation, Current
[custom:DueToRelatedPartiesCurrent1-0]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Accrued director fees
Separation expenses
Accrued salary and related expenses
Accrued stock-based compensation
D&O insurance premium financing (See Note 8)
Accrued professional fees
Accrued resale registration
Total other current liabilities
Deferred tax assets:
Research and development credit carryforwards
Capitalized research and development costs
Net operating loss carryforwards
Stock compensation
Total deferred tax assets
Total deferred tax liabilities
Net deferred tax assets
Valuation allowance for deferred tax assets
Net deferred tax assets
Income taxes (benefit) at federal statutory rate of 21.00%
Tax effect on non-deductible expenses and credits
True up items
Expiration of net operating loss carryforwards
Change in valuation allowance
Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Net operating loss carryforward
Indefinite position amount
Unrecognized tax benefits
2026
2027
Total minimum lease payments
Less amount representing imputed interest
Present value of minimum lease payments
Lease description
Lease frequency of periodic payment
Lease periodic payment
Remaining lease term
Lease weighted average discount rate
Operating lease expense
Premium financing agreement
Payment of financing cost
Premium financing agreement, net payable
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Research and development
Cash used in operating activities
Auditor Name [Default Label]
Auditor Location
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Interest Income (Expense), Nonoperating
Other Nonoperating Income
Other Noncash Income (Expense)
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Gain (Loss) on Disposition of Property Plant Equipment
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable, Related Parties
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payment, Tax Withholding, Share-Based Payment Arrangement
CommissionPaidRelatedToWarrantInducement
LegalFeesPaidRelatedToWarrantInducement
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Income Tax, Policy [Policy Text Block]
LessDisposals
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Finite-Lived Intangible Assets, Accumulated Amortization
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
TrueUpItems
Income Tax Expense (Benefit)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount